GlaxoSmithKline (GSK) plc

GSK to Invest $30 Billion in US R&D and Manufacturing

Includes $1.2 billion in manufacturing facilities, AI, and advanced digital technologies, creating hundreds of highly skilled US jobs.

GSK and Oxford University Collaborate on Cancer Vaccines

GSK and the University of Oxford have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The program, in which GSK plans to invest up to £50 million over a minimum of three years, will conduct translational research, exploring precancer biology to generate key insights on how cancer develops in humans that could inform future development of cancer vaccines.

GSK Acquires Lupus Drug Candidate from Chimagen Biosciences

GlaxoSmithKline (GSK) agreed to acquire a clinical-stage drug from Chimagen Biosciences, a privately held Chinese biotechnology company. CMG1A46 is a dual CD19 and CD20-targeted T cell-engager (TCE), which GSK plans to develop and commercialize with a focus on B cell-driven autoimmune diseases, such as systemic lupus erythematosus (SLE) and lupus nephritis (LN), with potential to expand into related autoimmune diseases.

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

GSK and Zhifei Co-Promote Shingles Vaccine in China

GSK has struck a deal with Chongqing Zhifei Biological Products to promote the British group's shingles vaccine, Shingrix, in China for an initial three-year period. Starting on Jan.1, 2024, Zhifei will have exclusive rights to import and distribute Shingrix in China through its service network of more than 30,000 vaccination points across the country.

GSK Names Julie Brown as First Female CFO

From next year, GSK’s top management will be led by a double female team, a pioneering move for the global pharmaceutical industry. The UK drugs giant this week announced the appointment of Julie Brown, the first woman to be its chief financial officer.

GSK’s Consumer Health Flotation Flags

The Jul.18 launch of GSK’s consumer healthcare spinoff Haleon on the London Stock Exchange – said to be the largest London listing in more than a decade – seems to have gone off more like a whimper than a bang.

Sanofi/GSK and Moderna Seal Vaccine Supply in Canada

Both the Sanofi/GlaxoSmithKline partnership and US vaccine producer Moderna this week announced new advance purchase agreements with Canada for their Covid-19 vaccine candidates.

Sanofi and GSK Ink EU Vaccine Deal

Sanofi and GSK have agreed a deal with the EU to supply up to 300 million doses of their recombinant protein-based Covd-19 vaccine pending regulatory approval, which is expected sometime in the first half of 2021.

Sanofi and GSK Seal Vaccine Deals with US and UK

Lagging behind other big names of late in announcing Covid-19 vaccine supply deals, French and British drugmakers Sanofi and GlaxoSmithkline together nailed down agreements with the US and UK at the end of last week. The companies have hinted that a deal with the EU could be reached shortly.

GSK to Make Adjuvants for Several Covid Vaccines

GSK in Manufacturing Pact with Samsung Biologics

Former GSK Vaccines Chief to Lead US Covid Sprint

GSK will Test Antibody to Treat Covid Patients

Sanofi and GSK Collaborate on COVID Vaccine

GSK Teams again with Innovax on COVID Vaccine

GSK Links with Immatics on Cancer Therapies

GSK to Split off Consumer Health JV

GSK Sells Travel Vaccines to Bavarian Nordic

GSK and Lyell Partner on Cancer Therapies

GSK Takes Ionis Liver Drug Option

GSK-Pfizer Complete Consumer Health JV

GSK Adds Facilities in Singapore

GSK to Add Vaccine Capacity in US

GSK Sells Vaccines Unit to Bharat Biotech

GSK and Pfizer Form Consumer Health JV

GSK Helps Launch New UK Biopharma Sitryx

European Drugmakers Deal with Misconduct

GSK Closes Stiefel Plant in Ireland

GSK’s Shingles Vaccine Captures US Market

Orchard Takes GSK’s Rare Disease Gene Therapies

GSK and Novartis Join Anti-Malaria Effort

GSK to Buy Novartis’ Share in Consumer JV

GSK Sees £70 million Short-term Brexit Cost

GSK Fined $54 Million in Pay-for-Delay

GSK said Eyeing Bid for Vectura

Management Reshuffle at GlaxoSmithKline

GSK Expands Stake in Saudi Subsidiary

US and Canada Approve GSK Shingles Vaccine

GSK Signs AI Pact with Exscientia

GSK Confirms £500 Million UK Investment Plans

GSK, Others Vie to Buy Turkish Drugmaker

Rx-360 Continues to Intensify Work in 2011

Glaxo Close to Buying Chinese Drugmaker